Project Details
Description
A Phase I Study of GNKG168 Administered by Intravenous Infusion in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/11 → 6/30/15 |
Funding
- SBI BIOTECH
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.